Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence - PubMed (original) (raw)
Clinical Trial
Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence
Arbeitsgemeinschaft für Pädiatrische Nephrologie. N Engl J Med. 1982.
Abstract
In a prospective, controlled study, 50 children with frequently relapsing nephrotic syndrome who had steroid toxicity were treated for eight weeks with either cyclophosphamide (2 mg per kilogram of body weight per day) or chlorambucil (0.15 mg per kilogram per day), in combination with prednisone in tapering doses. Of the 34 children shows relapses had tended to occur after the prednisone dosage had been reduced or immediately after the drug was discontinued (the steroid-dependent group), 22 also had early relapses after cytotoxic-drug treatment. In contrast, cytotoxic drug treatment produced long-lasting remissions in 12 of the 16 children whose relapses usually occurred after prednisone treatment had been interrupted for more than 14 days (the non-steroid-dependent group). The difference in response between the two groups was highly significant (P less than 0.001). We conclude that patients with frequent relapses without steroid dependence can be treated successfully with an eight-week course of cytotoxic drugs, whereas those with steroid-dependent nephrotic syndrome do not profit from cytotoxic drugs in the low doses used.
Similar articles
- Long-term evaluation of chlorambucil plus prednisone in the idiopathic nephrotic syndrome of childhood.
Williams SA, Makker SP, Ingelfinger JR, Grupe WE. Williams SA, et al. N Engl J Med. 1980 Apr 24;302(17):929-33. doi: 10.1056/NEJM198004243021701. N Engl J Med. 1980. PMID: 6987521 Clinical Trial. - [Treatment of corticoid-resistant nephrotic syndrome: a still unresolved problem].
Damiani B, Giani M, Consalvo G, Carcano A, Ghio L, Edefonti A. Damiani B, et al. Pediatr Med Chir. 1995 Jan-Feb;17(1):9-15. Pediatr Med Chir. 1995. PMID: 7739938 Review. Italian. - Management of the nephrotic syndrome.
Linshaw MA, Gruskin AB. Linshaw MA, et al. Clin Pediatr (Phila). 1974 Jan;13(1):45-51. doi: 10.1177/000992287401300105. Clin Pediatr (Phila). 1974. PMID: 4588668 Review. No abstract available.
Cited by
- Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
Larkins NG, Hahn D, Liu ID, Willis NS, Craig JC, Hodson EM. Larkins NG, et al. Cochrane Database Syst Rev. 2024 Nov 8;11(11):CD002290. doi: 10.1002/14651858.CD002290.pub6. Cochrane Database Syst Rev. 2024. PMID: 39513526 Review. - Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
Larkins NG, Liu ID, Willis NS, Craig JC, Hodson EM. Larkins NG, et al. Cochrane Database Syst Rev. 2020 Apr 16;4(4):CD002290. doi: 10.1002/14651858.CD002290.pub5. Cochrane Database Syst Rev. 2020. PMID: 32297308 Free PMC article. Updated. - Efficacy and acceptability of immunosuppressive agents for pediatric frequently-relapsing and steroid-dependent nephrotic syndrome: A network meta-analysis of randomized controlled trials.
Tan L, Li S, Yang H, Zou Q, Wan J, Li Q. Tan L, et al. Medicine (Baltimore). 2019 May;98(22):e15927. doi: 10.1097/MD.0000000000015927. Medicine (Baltimore). 2019. PMID: 31145359 Free PMC article. - Crohn's disease following rituximab treatment in a patient with refractory nephrotic syndrome.
Morita K, Shibano T, Maekawa K, Hattori M, Hida N, Nakamura S, Takeshima Y. Morita K, et al. CEN Case Rep. 2019 Feb;8(1):55-60. doi: 10.1007/s13730-018-0364-8. Epub 2018 Sep 24. CEN Case Rep. 2019. PMID: 30251194 Free PMC article. - Treating the idiopathic nephrotic syndrome: are steroids the answer?
Deschênes G, Dossier C, Hogan J. Deschênes G, et al. Pediatr Nephrol. 2019 May;34(5):777-785. doi: 10.1007/s00467-018-3963-x. Epub 2018 Jun 4. Pediatr Nephrol. 2019. PMID: 29869116 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical